Study Summary
This is an open, single-arm, clinical study to evaluate efficacy and safety of anti CD7 CAR-T cell in the treatment of CD7 Positive acute leukemia or mixed lineage leukemia except those who are diagnosed with T-ALL/T-LBL
Want to learn more about this trial?
Request More InfoInterventions
CD7 CARTBIOLOGICAL
Biological: CD7 CAR-T; Drug: Cyclophosphamide,Fludarabine; Procedure: Leukapheresis
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| He bei Yan da Lu dao pei Hospital | Beijingcun | Hebei | China |